Literature DB >> 17504108

Metabotropic glutamate receptors as drug targets.

Max Récasens1, Janique Guiramand, Rose Aimar, Ahmad Abdulkarim, Gérard Barbanel.   

Abstract

L-glutamate (Glu), the main excitatory amino acid neurotransmitter in the mammalian central nervous system, is involved in many physiological functions, including learning and memory, but also in toxic phenomena occurring in numerous degenerative or neurological diseases. These functions mainly result from its interaction with Glu receptors (GluRs). The broad spectrum of roles played by glutamate derived from the large number of membrane receptors, which are currently classified in two main categories, ionotropic (iGluRs) and metabotropic (mGluRs) receptors. The iGluRs are ion channels, permeant to Na(+) (Ca(2+)) while the mGluRs belongs to the superfamily of G-protein coupled receptors (GPCRs). Despite continuous efforts over more than two decades, the use of iGluR agonists or antagonists to improve or inhibit excitatory transmission in pathological states still remains a major challenge, though the discovery and development of recent molecules may prove it worthwhile. This probably results form the vital role of fast excitatory transmission in many fundamental physiological functions. Since the discovery of mGluRs, hope has emerged. Indeed, mGluRs are mainly involved in the regulation of fast excitatory transmission. Consequently, it was logically thought that modulating mGluRs with agonists or antagonists might lead to more subtle regulation of fast excitatory transmission than by directly blocking iGluRs. As a result of intensive investigation, new drugs permitting to discriminate between these receptors have emerged. Moreover, a new class of molecules acting as negative or positive allosteric modulators or mGluRs is now available and appears to be promising. In the following, we will review the classification of mGluRs and the functions in which mGluRs are involved. We will focus on their potential as therapeutic targets for improving numerous physiological functions and for different neurodegenerative and neuropsychiatric disorders, which are related to malfunction of Glu signaling in human beings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504108     DOI: 10.2174/138945007780618544

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  11 in total

1.  Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082.

Authors:  Michael C Salling; Sara Faccidomo; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2008-06-14       Impact factor: 3.533

2.  Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex.

Authors:  Dong Xi; Yan-Chun Li; Melissa A Snyder; Ruby Y Gao; Alicia E Adelman; Wentong Zhang; Jed S Shumsky; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

3.  Functional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines.

Authors:  Hannelore Goddyn; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-21       Impact factor: 5.176

Review 4.  Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.

Authors:  Mery Stefani Leivas Pereira; Fábio Klamt; Chairini Cássia Thomé; Paulo Valdeci Worm; Diogo Losch de Oliveira
Journal:  Oncotarget       Date:  2017-03-28

5.  Direct coupling of detergent purified human mGlu5 receptor to the heterotrimeric G proteins Gq and Gs.

Authors:  Chady Nasrallah; Karine Rottier; Romain Marcellin; Vincent Compan; Joan Font; Amadeu Llebaria; Jean-Philippe Pin; Jean-Louis Banères; Guillaume Lebon
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

Review 6.  Allosteric Molecular Switches in Metabotropic Glutamate Receptors.

Authors:  Zoltán Orgován; György G Ferenczy; György M Keserű
Journal:  ChemMedChem       Date:  2020-08-25       Impact factor: 3.466

7.  Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.

Authors:  Min-Juan Wang; Yan-Chun Li; Melissa A Snyder; Huaixing Wang; Feng Li; Wen-Jun Gao
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

8.  Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.

Authors:  J J Martino; B A Wall; E Mastrantoni; B J Wilimczyk; S N La Cava; K Degenhardt; E White; S Chen
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

9.  Pesticides Drive Stochastic Changes in the Chemoreception and Neurotransmission System of Marine Ectoparasites.

Authors:  Gustavo Núñez-Acuña; Sebastián Boltaña; Cristian Gallardo-Escárate
Journal:  Int J Mol Sci       Date:  2016-05-31       Impact factor: 5.923

10.  Genome-Wide Selective Signature Analysis Revealed Insecticide Resistance Mechanisms in Cydia pomonella.

Authors:  Wen-Ting Dai; Jin Li; Li-Ping Ban
Journal:  Insects       Date:  2021-12-21       Impact factor: 2.769

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.